14 research outputs found
A critical psychology of the postcolonial
Of the theoretical resources typically taken as the underlying foundations of critical social psychology, elements, typically, each of Marxism, feminism, psychoanalysis, and Post-Structuralism, one particular mode of critique remains notably absent: postcolonial theory. What might be the most crucial contributions that postcolonial critique can make to the project of critical psychology? One answer is that of a reciprocal forms of critique, the retrieval of a âpsychopoliticsâ in which we not only place the psychological within the register of the political, but - perhaps more challengingly - in which the political is also, strategically, approached through the register of the psychological. What the writings of Fanon and Biko make plain in this connection is the degree to which the narratives and concepts of the social psychological may be reformulated so as to fashion a novel discourse of resistance, one that opens up new avenues for critique for critical psychology, on one hand, and that affords an innovative set of opportunities for the psychological investigation of the vicissitudes of the postcolonial, on the othe
Mucosal leishmaniasis ("espundia") responsive to low dose of N-methyl glucamine (Glucantime Âź) in Rio de Janeiro, Brazil
The treatment ideal and detention reality: Demographic, professional/ occupational and organizational influences on detention worker punitiveness
Low efficacy of azithromycin to treat cutaneous leishmaniasis in Manaus, AM, Brazil Azitromicina para tratamento de leishmaniose cutĂąnea em Manaus, AM, Brasil
An open trial to evaluate the azithromycin efficacy in cutaneous leishmaniasis patients was carried out in Manaus (AM), where Leishmania (Viannia) guyanensis is the main etiologic agent. Forty-one patients with skin lesions of less than 12 weeks duration, without specific treatment for the last three months and a positive imprint to Leishmania sp. were included. From these, 31 (75.6%) were male with median age of 30.2. All of them received a daily-single oral dose of 500 mg of azithromycin for ten days. At 25th day, 16 (39%) presented therapeutic failure and received intramuscular pentavalent antimonial, four were considered lost, 21, that had improved or were inaltered received another ten-day series of azithromycin and were monthly followed, but nine (21.9%) of them presented a poor clinical response and switched to intramuscular pentavalent antimonial on day 55. Of the 12 remaining cases evaluated on day 55, despite of clinical improvement, three asked for antimony therapy and 9 (21.9%) continued the follow-up but, only three were cured on 55th, 85th and 115th days, and six did not come back for final evaluation. The intention-treatment overall response rate was 22% and whole cure was seen in three (7.3%) of cases. Thus, azithromycin showed a low efficacy to treat cutaneous leishmaniasis in Manaus.<br>Para avaliar a eficĂĄcia da azitromicina na leishmaniose cutĂąnea, foi realizado ensaio clĂnico em Manaus, Amazonas, onde o agente etiolĂłgico predominante Ă© a Leishmania (Viannia) guyanensis. IncluĂdos 41 pacientes com lesĂ”es de menos de 12 semanas, sem histĂłria de tratamento especĂfico nos Ășltimos trĂȘs meses e com esfregaço positivo para Leishmania sp. Destes, 31 (75,6%) eram masculinos, idade mĂ©dia 30,2 anos. Todos receberam azitromicina 500 mg em dose Ășnica oral, diĂĄria, por 10 dias. No dia 25Âș, 16 (39%) pioraram e receberam antimonial pentavalente via intramuscular por 20 dias e, 21 (61%) que apresentaram melhora da lesĂŁo ou esta permanecia inalterada no 25Âș dia, receberam outro ciclo de 10 dias de azitromicina e foram acompanhados mensalmente. Destes, nove (21,9%) apresentaram piora das lesĂ”es na avaliação do dia 55 e iniciaram tratamento com antimonial neste dia. Dos 12 que permaneceram no estudo, porque tinham melhorado clinicamente, trĂȘs optaram por tratamento com antimonial pentavalente no 55Âș dia e trĂȘs apresentaram reepitelização completa das lesĂ”es nos dias 55Âș, 65Âș e 115Âș. Seis pacientes nĂŁo retornaram para avaliação final. AnĂĄlise por tentativa de tratamento foi 22% e cura confirmada em trĂȘs (7,3%) casos. Estes resultados mostraram que azitromicina tem baixa eficĂĄcia para tratar leishmaniose em ĂĄrea onde a Leishmania (Viannia) guyanensis Ă© o agente etiolĂłgico predominante